- Home
- BMRN vs APPF Comparison
BMRN vs APPF Comparison
Compare BMRN & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- APPF
- Stock Information
- Founded
- BMRN 1996
- APPF 2006
- Country
- BMRN United States
- APPF United States
- Employees
- BMRN N/A
- APPF N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- APPF Computer Software: Prepackaged Software
- Sector
- BMRN Health Care
- APPF Technology
- Exchange
- BMRN Nasdaq
- APPF Nasdaq
- Market Cap
- BMRN 11.3B
- APPF 9.5B
- IPO Year
- BMRN 1999
- APPF 2015
- Fundamental
- Price
- BMRN $57.77
- APPF $284.81
- Analyst Decision
- BMRN Buy
- APPF Buy
- Analyst Count
- BMRN 23
- APPF 6
- Target Price
- BMRN $93.14
- APPF $309.83
- AVG Volume (30 Days)
- BMRN 1.8M
- APPF 287.3K
- Earning Date
- BMRN 10-28-2025
- APPF 10-23-2025
- Dividend Yield
- BMRN N/A
- APPF N/A
- EPS Growth
- BMRN 154.69
- APPF 64.56
- EPS
- BMRN 3.40
- APPF 5.55
- Revenue
- BMRN $3,063,608,000.00
- APPF $862,674,000.00
- Revenue This Year
- BMRN $13.32
- APPF $21.09
- Revenue Next Year
- BMRN $9.37
- APPF $17.60
- P/E Ratio
- BMRN $16.97
- APPF $51.32
- Revenue Growth
- BMRN 18.36
- APPF 19.47
- 52 Week Low
- BMRN $52.93
- APPF $189.01
- 52 Week High
- BMRN $90.01
- APPF $326.04
- Technical
- Relative Strength Index (RSI)
- BMRN 48.39
- APPF 61.20
- Support Level
- BMRN $55.99
- APPF $270.62
- Resistance Level
- BMRN $59.79
- APPF $278.80
- Average True Range (ATR)
- BMRN 1.37
- APPF 5.57
- MACD
- BMRN -0.05
- APPF -0.16
- Stochastic Oscillator
- BMRN 46.84
- APPF 98.80
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About APPF AppFolio Inc.
AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.